Mifepristone abortion outside the urban research hospital setting in India

Lancet

Volumn 357, Issue 9250, 2001, Pages 120-122

  Coyaji, Kurus ^a   Elul, Batya ^b   Krishna, Usha ^c   Otiv, Suhas ^a   Ambardekar, Shubha ^a   Bopardikar, Arti ^a   Raote, Veena ^c   Ellertson, Charlotte ^d   Winikoff, Beverly ^b  

^a KEM HOSPITAL   (India)

^b POPULATION COUNCIL   (United States)

^c Bhatia General Hospital   (India)

^d POPULATION COUNCIL   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ABORTIVE AGENT; MIFEPRISTONE; MISOPROSTOL;

ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FAMILY PLANNING; FEMALE; HUMAN; INDIA; INDUCED ABORTION; MAJOR CLINICAL STUDY; NAUSEA; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RURAL HEALTH CARE; VOMITING;

EID: 0035852475     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03549-2     Document Type: Article

References (5)

1. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol
2. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol: Results of a large multicenter trial in the United States
3. Safety, efficacy and acceptability of medical abortion in China, Cuba, and India: A comparative trial of mifepristone-misoprostol versus surgical abortion
4. Analysis of failure in medical abortion
5. Estimating the efficacy of medical abortion